Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESET-IT: Intermittent Insulin Therapy in Early Type 2 Diabetes
NCT02192424Phase 3Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Jul 2014
- Primary completion
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine, insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Mount Sinai Hospital. Started Jul 2014; status: completed.
02
Drugs
insulin glargineinsulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02192424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192424.